ArticleBMJ global health2025

Disparities in dolutegravir utilisation in children, adolescents and young adults (0-24 years) living with HIV. An analysis of the IeDEA Pediatric West African cohort.

Sophie Desmonde et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.